Quick Answer
MEDICINOVA INC reported Cash And Cash Equivalents At Carrying Value of $30.81 million for the year ending 2025.
- MEDICINOVA INC showed a decrease of -23.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), MEDICINOVA INC's Cash And Cash Equivalents At Carrying Value has grown by 59.6%.
- Historical annual values: Fiscal year 2025: $30.81 million | Fiscal year 2024: $40.36 million | Fiscal year 2023: $51.00 million | Fiscal year 2022: $18.51 million | Fiscal year 2021: $71.43 million | Fiscal year 2020: $60.04 million | Fiscal year 2019: $63.79 million | Fiscal year 2018: $62.31 million | Fiscal year 2017: $27.99 million | Fiscal year 2016: $24.12 million | Fiscal year 2015: $22.08 million | Fiscal year 2014: $11.67 million | Fiscal year 2013: $6.70 million | Fiscal year 2012: $4.01 million | Fiscal year 2011: $15.09 million | Fiscal year 2010: $28.25 million | Fiscal year 2009: $19.24 million | Fiscal year 2008: $19.30 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: